2nd Quarter - Report

FOLEY HOAG LLP for ADAMAS PHARMACEUTICALS

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of pandemic and biodefense preparedness legislation.

LobbyistCovered position, as disclosed
KELLY CHILDRESS —
PAUL KIM —
NICK LITTLEFIELD —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.